ghrelin and glp-1 Is a glucagon‐like peptide‐1 secretagogue? - Ueno - 2016 - Journal of Diabetes Investigation Effect of feeding and fasting

Weve found that people generally tolerate GLP-1 for weight loss well, and the side effect profile seems to be fairly mild and predictable

But for the right patients, combined with comprehensive support, they can be genuinely helpful for both weight and mental health

Injecting too fast forces a large bolus of liquid into a small subcutaneous space, which can cause pain, lump formation, and potentially altered absorption kinetics

To understand why shedding happens, it helps to look at the hair growth cycle

Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications primarily prescribed for type 2 diabetes management and, in some formulations, for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity